Hims (HIMS): FY25 Q1 earnings call, May 5, 2025

Mon, May 5Earnings callSpeaker-labelled transcriptHims

No Kalshi or Polymarket word markets were listed for Hims’s May 5, 2025 earnings call (FY25 Q1). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

7 matches for “Testosterone”; 5 quoted, at least 25 words apart.

Andrew Dudumcompanyprepared

…our success in weight loss, we are launching new offerings in low testosterone and menopause support this year, with longer term opportunities emerging in longevity,…

Andrew Dudumcompanyprepared

…is especially important as we expand into hormone driven conditions like low testosterone and menopause. There are over 50 million people in The United States…

Andrew Dudumcompanyprepared

…positioned to meet these needs. We expect to launch both a low testosterone and menopause support offering before the end of this year. As we…

Yemi Okupecompanyprepared

…that fold additional benefits in areas like vitamin support, hair loss prevention, testosterone support, and cardiovascular health are allowing us to elevate the experience for…

Yemi Okupecompanyprepared

…those that we expect to be in the future, such as low testosterone, that require sterile capabilities. In the coming quarters, we will also invest…

Agents: this page as TSV at /api/v1/appearances/hims:2025-05-05:earnings_call · words: /api/v1/brief?appearance=hims:2025-05-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP